Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact firstname.lastname@example.org.
Gaps in the Type 2 Diabetes Care Cascade and How HIV and/or Active Tuberculosis Disease Impact Movement Through its Stages: A National Perspective Using South Africa's National Health Laboratory Service (NHLs) Database
17 Pages Posted: 12 Sep 2022More...
Background: Research out of South Africa estimates the total unmet need for care for those with type 2 diabetes mellitus(diabetes) at 80%. We evaluated the care cascade using South Africa’s National Health Laboratory Service(NHLS) database and assessed if HIV and/or tuberculosis(TB) impact progression through its stages.
Methods: The cohort includes patients from government facilities with their first glycated hemoglobin A1c(HbA1c) or plasma glucose(fasting(FPG); random(RPG)) measured between January 2012 and March 2015 in the NHLS. Lab-diagnosed diabetes was defined as HbA1c ≥6.5%, FPG≥7.0mmol/l, or RPG≥11.1mmol/l. Cascade stages post diagnosis were remaining-in-care and glycaemic control(defined as an HbA1c<7.0% or FPG<8.0mmol/l or RPG<10.0mmol/l) over 24-months. We estimated gaps at each stage nationally and by HIV and/or TB infection.
Findings: Of the 373,889 patients tested for diabetes, 42.8% had an HbA1c or blood glucose measure indicating a diabetes diagnosis. Amongst those with lab-diagnosed diabetes, 30.5% remained-in-care and 8.6% reached glycaemic control by 24-months. Irrespective of TB infection, prevalence of lab-diagnosed diabetes in PLWH was 28.3% versus 46.9% in HIV-uninfected individuals. Among those with lab-diagnosed diabetes, 34.2% of PLWH remained-in-care versus 29.9% HIV-uninfected. Among people remaining in care, 33.7% of PLWH reached glycaemic control over 24-months versus 28.1% of HIV-uninfected individuals.
Interpretation: In a national cohort of patients undergoing lab-based screening for diabetes, only 30.5% of those with diabetes remained-in-care and <10% achieved glycaemic control 24-months post diagnosis. PLWH versus HIV-uninfected had a lower prevalence of diabetes and were more likely to complete the cascade stages, possibly because of differences in access to medical care.
Funding: National Institute of Diabetes and Digestive and Kidney Diseases 1K01DK116929-01A1.
Declaration of Interest: We declare no competing interests.
Ethical Approval: Approval for analysis of de-identified NHLS data was granted by Boston University’s Institutional Review Board(protocol No.H-31968), Human Research Ethics Committee of the University of the Witwatersrand(protocol No.M200851) and NHLS Academic Affairs and Research Management System(protocol No.PR20270).
Keywords: type 2 diabetes mellitus, HIV/AIDS, tuberculosis, South Africa, care cascade
Suggested Citation: Suggested Citation